Invention Grant
- Patent Title: Intranasal formulation of rotigotine
- Patent Title (中): 罗替戈汀的鼻内制剂
-
Application No.: US10545530Application Date: 2004-12-22
-
Publication No.: US07683040B2Publication Date: 2010-03-23
- Inventor: Robert Krämer
- Applicant: Robert Krämer
- Applicant Address: US DE Wilmington
- Assignee: SRZ Properties, Inc.
- Current Assignee: SRZ Properties, Inc.
- Current Assignee Address: US DE Wilmington
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: EP03029680 20031223
- International Application: PCT/EP2004/014626 WO 20041222
- International Announcement: WO2005/063236 WO 20050714
- Main IPC: A61K31/724
- IPC: A61K31/724 ; A61K31/381
Abstract:
This invention pertains to a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and α-cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5-1.5 mm2/s.
Public/Granted literature
- US20070191308A1 Intranasal formulation of rotigotine Public/Granted day:2007-08-16
Information query
